According to a press release, “Cryoport, Inc., the world’s leading cryogenic logistics company, today announced that one of the world’s foremost contract manufacturers to the biopharma industry will convert its fleet of liquid nitrogen dewars supporting shipping of its contract manufacturing biologics and cell therapy businesses to Cryoport’s industry-leading and comprehensive logistics solutions.”  For more information, please visit: